Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 75, Issue 1, 2010, Pages 48-55

  de Campos Araújo, Luciana Mattoso Pires ^a   Thomazine, José Antônio ^a   Lopez, Renata Fonseca Vianna ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

5 Aminolevulinic acid; Microemulsion; Photodynamic therapy; Protoporphyrin; Skin penetration

Indexed keywords

AMINOLEVULINIC ACID; OLEIC ACID ETHYL ESTER; PROTOPORPHYRIN; RED FLUORESCENT PROTEIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONDUCTANCE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; IN VITRO STUDY; IN VIVO STUDY; MICROEMULSION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; SKIN PENETRATION; SWINE; VISCOSITY;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; EMULSIONS; MICE; MICE, HAIRLESS; PHOTOCHEMOTHERAPY; SKIN ABSORPTION; SWINE;

EID: 77951652824     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.01.008     Document Type: Article

References (48)

1. Donnelly R.F., McCarron P.A., Woolfson A.D. Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy. Photochem. Photobiol. 2005, 81:750-767.
2. Lopez R.F., Bentley M.V., Delgado-Charro M.B., Guy R.H. Optimization of aminolevulinic acid delivery by iontophoresis. J. Control. Release 2003, 88:65-70.
3. Lopez R.F., Lange N., Guy R.H., Bentley M.V. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv. Drug Deliv. Rev. 2004, 56:77-94.
4. Hurlimann A.F., Hanggi G., Panizzon R.G. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion. Dermatology 1998, 197:248-254.
5. Casas A., Perotti C., Saccoliti M., Sacca P., Fukuda H., Batlle A.M. ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures. Br. J. Cancer. 2002, 86:837-842.
6. Merclin N., Bender J., Sparr E., Guy R.H., Ehrsson H., Engstrom S. Transdermal delivery from a lipid sponge phase-iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester. J. Control. Release 2004, 100:191-198.
7. R.L. Bronaugh, H.T. Maibach, Percutaneous Absorptions: Drugs Cosmetics Mechanisms Methodology, third ed., Marcel Dekker, New York, 1999.
8. Djordjevic L., Primorac M., Stupar M., Krajisnik D. Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug. Int. J. Pharm. 2004, 271:11-19.
9. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv. Drug Del. Rev. 2002, Suppl. 54(1):77-98.
10. Stilbs P., Lindman B. NMR measurements on microemulsions. Prog. Coll. Polym. Sci. 1984, 69:39-47.
11. Lawrence M.J. Surfactant systems: microemulsions and vesicles as vehicles for drug delivery. Eur. J. Drug Metab. Pharmacokinet. 1994, 19:257-269.
12. Kreilgaard M. Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis. Pharm. Res. 2001, 18:367-373.
13. Delgado-Charro M.B., Iglesias-Vilas G., Blanco-Mendez J., Lopez-Quintela M.A., Marty J.P., Guy R.H. Delivery of a hydrophobic solute through the skin from novel microemulsion systems. Eur. J. Pharm. Biopharm. 1997, 43:37-42.
14. Rhee Y., Choi J., Park E., Chi S. Transdermal delivery of ketoprofen using microemulsions. Int. J. Pharm. 2001, 228:161-170.
15. Lopez R.F., Bentley M.V., Delgado-Charro M.B., Salomon D., Van Den B.H., Lange N., Guy R.H. Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro. Photochem. Photobiol. 2003, 77:304-308.
16. US Food and Drug Administration, Center for Drug Evaluation and Research, Guidance for Industry: Bioanalytical Method Validation, Office of Training and Communications, Division of communications Management, Drug information Branch, HDF 210, Rockville Maryland 20857, May 2001, 2001.
17. Merclin N., Bramer T., Edsman K. Iontophoretic delivery of 5-aminolevulinic acid and its methyl ester using a carbopol gel as vehicle. J. Control. Release 2004, 98:57-65.
18. De Rosa F.S., Marchetti J.M., Thomazini J.A., Tedesco A.C., Bentley M.V. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J. Control. Release 2000, 65:359-366.
19. De Rosa F.S., Tedesco A.C., Lopez R.F., Pierre M.B., Lange N., Marchetti J.M., Rotta J.C., Bentley M.V. In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J. Control. Release 2003, 89:261-269.
20. Bennet K.E., Hatfield J.C., Davis H.T., Mascosko C.W., Scriven L.E. Viscosity and conductivity of microemulsions. Microemulsions 1982, 65-84. Plenum Press, New York. I.D. Robb (Ed.).
21. Zielinska K., Wilk K.A., Jezierski A., Jesionowski T. Microstructure and structural transition in microemulsions stabilized by aldonamide-type surfactants. J. Colloid Interface Sci. 2008, 321:408-417.
22. Bumajdad A., Eastoe J. Conductivity of water-in-oil microemulsions stabilized by mixed surfactants. J. Colloid Interface Sci. 2004, 274:268-276.
23. Graf A., Jack K.S., Whittaker A.K., Hook S.M., Rades T. Protein delivery using nanoparticles based on microemulsions with different structure-types. Eur. J. Pharm. Sci. 2008, 33:434-444.
24. Novo M., Huttmann G., Diddens H. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. J. Photochem. Photobiol. B 1996, 34:143-148.
25. Elfsson B., Wallin I., Eksborg S., Rudaeus K., Ros A.M., Ehrsson H. Stability of 5-aminolevulinic acid in aqueous solution. Eur. J. Pharm. Sci. 1999, 7:87-91.
26. Bunke A., Zerbe O., Schmid H., Burmeister G., Merkle H.P., Gander B. Degradation mechanism and stability of 5-aminolevulinic acid. J. Pharm. Sci. 2000, 89:1335-1341.
27. De Blois A.W., Grouls R.J., Ackerman E.W., Wijdevenk W.J. Development of a stable solution of 5-aminolevulinic acid for intracutaneous injection in photodynamic therapy. Lasers Med. Sci. 2002, 17:208-215.
28. Zhu W., Guo C., Yu A., Gao Y., Cao F., Zhai G. Microemulsion-based hydrogel formulation of penciclovir for topical delivery. Int. J. Pharm. 2009, 378(1-2):152-158.
29. Peng Q., Warloe T., Moan J., Heyerdahl H., Steen H.B., Nesland J.M., Giercksky K.E. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem. Photobiol. 1995, 62:906-913.
30. Peng Q., Soler A.M., Warloe T., Nesland J.M., Giercksky K.E. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J. Photochem. Photobiol. B 2001, 62:140-145.
31. Steluti R., De Rosa F.S., Collett J., Tedesco A.C., Bentley M.V. Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. Eur. J. Pharm. Biopharm. 2005, 60:439-444.
32. Fang Y., Wu P., Tsai Y., Huang Y. Physicochemical and safety evaluation of 5-aminolevulinic acid in novel liposomes as carrier for skin delivery. J. Liposome Res. 2008, 18:31-45.
33. Grüning N., Müller-Goymann C.C. Physicochemical characterization of a novel thermogelling formulation for percutaneous penetration of 5-aminolevulinic acid. J. Pharm. Sci. 2008, 97:2311-2323.
34. Winkler A., Muller-Goymann C.C. The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum. Eur. J. Pharm. Biopharm. 2005, 60:427-437.
35. Tokuoka Y., Suzuki M., Ohsawa Y., Ochiai A., Ishizuka M., Kawashima N. Enhancement in skin permeation of 5-aminolevulinic acid using l-menthol and its derivates. Drug Dev. Ind. Pharm. 2008, 34:595-601.
36. Pierre M.B., Ricci E., Tedesco A.C., Bentley M.V. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy. Pharm. Res. 2006, 23:360-366.
37. Bond J.R., Barry B.W. Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin. J. Invest. Dermatol. 1988, 90:810-813.
38. Bond J.R., Barry B.W. Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: hydration damage. J. Invest. Dermatol. 1988, 90:486-489.
39. Rigg P.C., Barry B.W. Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J. Invest. Dermatol. 1990, 94:235-240.
40. Sato K., Sugibayashi K., Morimoto Y. Species differences in percutaneous absorption of nicorandil. J. Pharm. Sci. 1991, 80:104-107.
41. Ogiso T., Iwaki M., Paku T. Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J. Pharm. Sci. 1995, 84:482-488.
42. Pereira G.R., Collet J.H., Garcia S.B., Thomazini J.A., Bentley M.V.L.B. Glycerol monooleate/solvents systems for progesterone transdermal delivery: in vitro permeation and microscopic studies. Braz. J. Pharm. Sci. 2002, 38:55-62.
43. Herai H., Gratieri T., Thomazine J.A., Bentley M.V., Lopez R.F. Doxorubicin skin penetration from monoolein-containing propylene glycol formulations. Int. J. Pharm. 2007, 329:88-93.
44. Maish T., Worlicek C., Babilas P., Landthaler M., Szeimies R. A HCl/alcohol formulation increased 5-aminolevulinic acid skin distribution using and ex vivo full thickness porcine skin model. Exp. Dermatol. 2008, 17:813-820.
45. Bender J., Ericson M.B., Merclin N., Iani V., Rosén A., Engstrom S., Moan J. Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J. Control. Release 2005, 106:350-360.
46. Donnelly R.F., Morrow D.I.J., McCarron P.A., Woolfson A.D., Morrissey A., Juzenas P., Juzeniene A., McCarthy H.O., Moan J. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential enhanced topical photodynamic therapy. J. Control. Release 2008, 129:154-162.
47. Lopez R.F., Bentley M.V., Delgado-Charro M.B., Guy R.H. Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH. Pharm. Res. 2001, 18:311-315.
48. Divaris D.X., Kennedy J.C., Pottier R.H. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am. J. Pathol. 1990, 136:891-897.